ArticleProceedings of the National Academy of Sciences of the United States of America2019

Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies.

Florence Borot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.